Free shipping on all orders over $ 500

Royal Jelly acid

Cat. No. M9331

All AbMole products are for research use only, cannot be used for human consumption.

Royal Jelly acid Structure
Synonym:

10-Hydroxy-trans-2-decenoic acid; 10-H2DA

Size Price Availability Quantity
10mg USD 25  USD25 In stock
25mg USD 35  USD35 In stock
50mg USD 50  USD50 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Royal Jelly acid (10-hydroxy-2-decenoic acid) is the principal lipid component in royal jelly which is the food for queen and larvae honeybees. Royal Jelly acid (Queen Bee Acid) promotes the growth and protection of neurons, reduces anxiety-like phenotypes.

Product Citations
Chemical Information
Molecular Weight 186.25
Formula C10H18O3
CAS Number 14113-05-4
Solubility (25°C) DMSO 60 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Anna Kurek-Grecka, et al. Bee Products in Dermatology and Skin Care

[2] Wen-Ting Wei, et al. Geographical influences on content of 10-hydroxy-trans-2-decenoic acid in royal jelly in China

[3] Tsuyoshi Sugiyama, et al. Inhibitory mechanism of 10-hydroxy-trans-2-decenoic acid (royal jelly acid) against lipopolysaccharide- and interferon-β-induced nitric oxide production

[4] Tsuyoshi Sugiyama, et al. Royal jelly acid, 10-hydroxy-trans-2-decenoic acid, as a modulator of the innate immune responses

[5] Tsuyoshi Sugiyama, et al. Inhibitory effect of 10-hydroxy-trans-2-decenoic acid on LPS-induced IL-6 production via reducing IκB-ζ expression

Related NF-κB Products
DCZ5418 

DCZ5418 is an inhibitor of TRIP13.

Ro 106-9920 

Ro 106-9920 is a potent inhibitor of NF-kappaB.

MRS2693 trisodium 

MRS2693 trisodium is a selective P2Y6 agonist with an EC50 value of 0.015 μM.

PTD-p65-P1 Peptide TFA

PTD-p65-P1 Peptide TFA is a potent, selective nuclear transcription factor NF-κB inhibitor and derives from the p65 subunit of NF-κB amino acid residues 271-282, which selectively inhibits NF-κB activation induced by various inflammatory stimulation, down-regulate NF-κB-mediated gene expression and up-regulate apoptosis.

Narlumosbart

Narlumosbart is a human IgG4ҡ monoclonal antibody (mAb) that targets Receptor Activating Factor for Nuclear Factor κB Ligand (RANKL) and can be used in studies related to Giant Cell Tumor of Bone (GCTB).

  Catalog
Abmole Inhibitor Catalog




Keywords: Royal Jelly acid, 10-Hydroxy-trans-2-decenoic acid; 10-H2DA supplier, NF-κB, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.